March 29, 2013
/PRNewswire/ -- Life Care Medical Devices Limited ("LCMD Hong Kong"), a development stage medical device company developing and commercializing its Keyhole Cup device for use in laparoscopic surgery and its EPIOS Pain Management System, is pleased to announce the closing of its share exchange and reorganization with Health In Harmony Inc., a
corporation (OTCQB: HTHH). Following the share exchange and reorganization, LCMD Hong Kong became a wholly-owned subsidiary of Health In Harmony. Furthermore, Health In Harmony changed its name to Life Care Medical Devices Limited ("LCMD Nevada"), and its shares will continue to be listed on the OTC QB market. In connection with the share exchange and reorganization, LCMD Nevada appointed two new directors, to be effective
April 12, 2013
As part of the terms of the share exchange and reorganization, LCMD Hong Kong's stockholders exchanged all of their beneficially owned shares of LCMD Hong Kong common stock for an aggregate of 29,200,000 shares of common stock of LCMD Nevada, which constitutes approximately 83.4% of the issued and outstanding common stock of LCMD Nevada post-closing. Details of the share exchange transaction can be found in LCMD Nevada's Current Report on Form 8-K to be filed with the United States Securities and Exchange Commission (the "SEC").
Following the share exchange and reorganization, the directors of LCMD Nevada include existing director Nickolay V. Kukekov, Ph.D, and directors-elect
and Arthur Malvett. Furthermore, Mr. Foley has been appointed Chief Executive Officer of LCMD Nevada and Mr. Malvett has been appointed Chief Operating Officer of LCMD Nevada. Details on the appointments can be found in the Information Statement expected to be filed with the SEC on
April 1, 2013
About Life Care Medical Devices Limited
Life Care Medical Devices Limited is a development stage medical device company developing and commercializing its Keyhole Cup device for use in laparoscopic surgery and its EPIOS Pain Management System. The Keyhole Cup is a proprietary, patent-in-process protected device for use in laparoscopic surgery. The EPIOS Pain Management System, its second product in development, is designed to address pain management without drugs or hardware devices, as a low cost, disposable product.
For more information visit:
This release may contain certain forward-looking statements regarding our prospective performance and strategies within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of said safe harbor provisions.
Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of our company, are generally identified by use of words "anticipate," "believe," "estimate," "expect," "intend," "plan," "project," "seek," "strive," "try," or future or conditional verbs such as "could," "may," "should," "will," "would," or similar expressions. Our ability to predict results or the actual effects of our plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Some of the factors that could cause our actual results to differ from its expectations or beliefs include, without limitation, the risks discussed from time to time in our filings with the Securities and Exchange Commission.